EBO ebos group limited

(Adds detail) Nov 22 (Reuters) - Australasian pharmaceutical...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    (Adds detail)

    Nov 22 (Reuters) -

    Australasian pharmaceutical manufacturer EBOS Group (EBO) said on Wednesday it would not proceed with a potential major transaction in the animal care segment.

    The statement did not name its takeover target but local media had reported the company would acquire TPG Capital-backed pets and vets business Greencross.

    The Australian Financial Review reported that EBOS would pay A$3.75 billion ($2.44 billion) to acquire Greencross, without citing sources, and were set to raise about A$2 billion as early as Wednesday.

    In a stock exchange announcement, EBOS said "it has recently been engaged in discussions regarding a potential strategic transaction related to its Animal Care segment."

    "These discussions have now concluded and a transaction will not proceed"

    EBOS shares had been in a trading halt ahead of an announcement related to the deal.

    ($1 = 1.5366 Australian dollars)

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$26.91
Change
0.030(0.11%)
Mkt cap ! $5.479B
Open High Low Value Volume
$26.88 $27.17 $26.80 $816.4K 30.32K

Buyers (Bids)

No. Vol. Price($)
4 82 $26.90
 

Sellers (Offers)

Price($) Vol. No.
$26.92 403 9
View Market Depth
Last trade - 11.31am 10/09/2025 (20 minute delay) ?
EBO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.